Aclaris Therapeutics, Inc. Quarterly Operating Margin in % from Q2 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Aclaris Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q2 2018 to Q3 2024.
  • Aclaris Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -171 %, a 70.1% increase year-over-year.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -171 +400 +70.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -211 +148 +41.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -278 +49.7 +15.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -312 -9.54 -3.16% Oct 1, 2023 Dec 31, 2023
Q3 2023 -571 -215 -60.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -358 +995 +73.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -327 +917 +73.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -302 +1.03K +77.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -356 +819 +69.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.35K -289 -27.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.24K -311 -33.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.33K -542 -69% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.18K -260 -28.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.06K +152 +12.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -933 +1.34K +59% Jan 1, 2021 Mar 31, 2021
Q4 2020 -785 +1.84K +70.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -915 +467 +33.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.22K +117 +8.77% Apr 1, 2020 Jun 30, 2020
Q1 2020 -2.28K -1.45K -174% Jan 1, 2020 Mar 31, 2020
Q4 2019 -2.63K -1.74K -197% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.38K -56.4 -4.26% Jul 1, 2019 Sep 30, 2019
Q2 2019 -1.33K +41.4 +3.01% Apr 1, 2019 Jun 30, 2019
Q1 2019 -832 Jan 1, 2019 Mar 31, 2019
Q4 2018 -885 Oct 1, 2018 Dec 31, 2018
Q3 2018 -1.33K Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.38K Apr 1, 2018 Jun 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.